Company Filing History:
2 out of 2,310 
2 out of 1,274 
2 out of 87 
Years Active: 2021-2025
Title: **Brent Koehn: Innovative Approaches to Treating Graft-Versus-Host Disease and Tumors**
Introduction
Brent Koehn, an inventive mind hailing from Elk River, Minnesota, has made significant strides in the field of medical innovation. With two patents to his name, Koehn is on the cutting edge of therapeutic methods that address complex medical conditions such as graft-versus-host disease (GvHD) and tumors.
Latest Patents
Koehn's latest patents focus on therapeutic methods involving the modulation of inflammasome activation of myeloid-derived suppressor cells (MDSCs). One method specifically targets subjects who have or are at risk of developing graft-versus-host disease. This approach involves the administration of a plurality of MDSCs that are effective in alleviating symptoms or clinical signs of GvHD compared to a suitable control subject. Another aspect of his patented work deals with tumor treatment, which includes the co-administration of an anti-tumor therapy along with an inflammasome inciting agent. This combination aims to enhance the activation of MDSCs sufficiently to diminish their suppressor function, thereby improving the efficacy of cancer treatments.
Career Highlights
Brent Koehn has honed his expertise while working at renowned institutions such as the University of Minnesota and the University of North Carolina at Chapel Hill. His involvement in these esteemed entities has undoubtedly enriched his knowledge and contributed to his innovative breakthroughs in medical therapies.
Collaborations
Throughout his career, Koehn has collaborated with notable individuals in his field, including Peter J. Murray and Jenny P. Y. Ting. These partnerships have likely facilitated a robust exchange of ideas, leading to further advancements in therapeutic methodologies.
Conclusion
Brent Koehn represents the spirit of innovation in the medical field, specifically in the treatment of graft-versus-host disease and tumors. With his notable patents and collaborative efforts, Koehn continues to contribute valuable knowledge and advancements that may lead to improved patient outcomes. His work exemplifies the potential of medical innovation in transforming lives.